Kalevi Pyörälà
Impact in
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Diabetes Management and Research
- Cardiology and Cardiovascular Medicine top 0.05%
- Cardiovascular Function and Risk Factors
- Blood Pressure and Hypertension Studies
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 55
- Diabetes Treatment and Management 17
-
- Cardiovascular Function and Risk Factors 31
- Cardiac electrophysiology and arrhythmias 13
- Acute Myocardial Infarction Research 12
- Co-authors
- Markku Laakso (62 shared papers)Seppo Lehto (38 shared papers)Tapani Rönnemaa (24 shared papers)Steven M. Haffner (7 shared papers)Ole Færgeman (14 shared papers)John Kjekshus (12 shared papers)Anders Olsson (8 shared papers)Guy De Backer (12 shared papers)
- Journals
- Diabetes Care (30 papers)European Heart Journal (13 papers)Circulation (11 papers)The American Journal of Cardiology (9 papers)The Lancet (8 papers)
- Partner nations
- FinlandUnited StatesUnited Kingdom
In The Last Decade
Kalevi Pyörälà
225 papers receiving 33.4k citations
Kalevi Pyörälà's Hit Papers
Peers
Comparison fields: 5 of 177
- Endocrinology, Diabetes and Metabolism 12.1k
- Cardiology and Cardiovascular Medicine 9.2k
- Surgery 10.4k
- Family Practice 215
- Cancer Research 1.7k
Countries citing papers authored by Kalevi Pyörälà
This map shows the geographic impact of Kalevi Pyörälà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalevi Pyörälà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalevi Pyörälà more than expected).
Fields of papers citing papers by Kalevi Pyörälà
This network shows the impact of papers produced by Kalevi Pyörälà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalevi Pyörälà. The network helps show where Kalevi Pyörälà may publish in the future.
Co-authors
The 25 scholars most cited alongside Kalevi Pyörälà, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 235 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Hit paper breakdown → | 1994 | 7099 |
| 2 | Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction Hit paper breakdown → | 1998 | 5389 |
| 3 | Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Hit paper breakdown → | 1997 | 1256 |
| 4 | Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2 Hit paper breakdown → | 1998 | 1030 |
| 5 | Prevention of coronary heart disease in clinical practice Hit paper breakdown → | 1994 | 914 |
| 6 | Diabetes and atherosclerosis: An epidemiologic view Hit paper breakdown → | 1987 | 772 |
| 7 | Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland Hit paper breakdown → | 1979 | 671 |
| 8 | Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries Hit paper breakdown → | 2009 | 635 |
| 9 | EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries Hit paper breakdown → | 2009 | 629 |
| 10 | Impact of Diabetes on Mortality After the First Myocardial Infarction Hit paper breakdown → | 1998 | 529 |
| 11 | Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S) Hit paper breakdown → | 1998 | 500 |
| 12 | 1998 | 469 | |
| 13 | 1994 | 456 | |
| 14 | Incidence of Community-Acquired Pneumonia in the Population of Four Municipalities in Eastern Finland Hit paper breakdown → | 1993 | 445 |
| 15 | 2004 | 426 | |
| 16 | 1991 | 424 | |
| 17 | 1997 | 397 | |
| 18 | 1998 | 367 | |
| 19 | 2003 | 360 | |
| 20 | 2005 | 344 |
About Kalevi Pyörälà
Kalevi Pyörälà is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Surgery, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 235 papers that have together received 36.1k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (55 papers), Cardiovascular Function and Risk Factors (31 papers), Lipoproteins and Cardiovascular Health (24 papers), Metabolism, Diabetes, and Cancer (17 papers), Diabetes Treatment and Management (17 papers), Cardiac Imaging and Diagnostics (16 papers), Cardiac electrophysiology and arrhythmias (13 papers) and Acute Myocardial Infarction Research (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (12.1k citations), Cardiology and Cardiovascular Medicine (9.2k citations), Surgery (10.4k citations), Family Practice (215 citations) and Cancer Research (1.7k citations). Kalevi Pyörälà has collaborated with scholars based in Finland, United States and United Kingdom. Frequent co-authors include Markku Laakso, Seppo Lehto, Tapani Rönnemaa, Steven M. Haffner, Ole Færgeman, John Kjekshus, Anders Olsson, Guy De Backer, Lars Wilhelmsen and Matti Uusitupa. Their work appears in journals such as Diabetes Care, European Heart Journal, Circulation, The American Journal of Cardiology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.